Last reviewed · How we verify
NCT04230460: CIDA
Cannabis Impairment Detection Application (CIDA)
NA trial testing Cannabis (THC) (Inhaled) Placebo in Driving Under the Influence in 124 participants. Completed in 27 May 2021.
27 May 2021
Quick facts
| Lead sponsor | Advanced Brain Monitoring, Inc. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | triple |
| Primary purpose | basic science |
| Enrollment | 124 |
| Start date | 1 September 2020 |
| Primary completion | 27 May 2021 |
| Estimated completion | 27 May 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Cannabis (THC) (Inhaled) Placebo — full drug profile →
- Cannabis (High% THC) (Inhaled) — full drug profile →
- Cannabis (Very High% THC) (Inhaled) — full drug profile →
- Alcohol (oral)
Conditions studied
- Driving Under the Influence — all drugs for Driving Under the Influence →
- Marijuana Intoxication — all drugs for Marijuana Intoxication →
- Alcohol Intoxication — all drugs for Alcohol Intoxication →
Sponsor
Advanced Brain Monitoring, Inc. — full company profile →
Who can join
Adults 18 to 50, any sex, with Driving Under the Influence or Marijuana Intoxication. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Subjects will participate in a 4-visit study protocol in which they will be asked to complete a set of computerized tasks and a 45-minute simulated drive in a driving simulator. Subjects will be administered marijuana of varying pre-determined concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) during 3 of the visits and alcohol during one of the visits. Throughout the duration of each visit, brain activity will be measured noninvasively using an electroencephalogram (EEG) headset. The purpose of this study is to: 1. Further understand the effects of acute cannabis intoxication on driving performance in a driving simulator 2. Develop and refine brain-based biomarkers of impairment due to acute cannabis intoxication
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04230460
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Driving Under the Influence
Currently open trials in the same condition.
- NCT07401628 — In-Vehicle Real-Time Cannabis Influenced Driving Detection · NA · recruiting
- NCT05526196 — Combined and Separate Effects of Cannabis and Tobacco: Psychomotor, Subjective and Physiological Outcomes · NA · recruiting
- NCT04450966 — Adolescent Substance Use Prevention Intervention Research Study in Pediatric Primary Care · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04230460 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Advanced Brain Monitoring, Inc.
- Last refreshed: 12 July 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04230460.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing